A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver Cancer

Clinical trial NCT02828124 · TERMINATED

Trial details

NCT number: NCT02828124
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2016-08-23
Primary completion: 2018-01-08
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.